Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pioneering AI Automatically Diagnoses Lung Diseases from X-Ray Images

By HospiMedica International staff writers
Posted on 08 Nov 2022

Tuberculosis and pneumonia – potentially serious infections which mainly affect the lungs –often require a combination of different diagnostic tests– such as CT scans, blood tests, X-rays, and ultrasounds. More...

These tests can be expensive, with often lengthy waiting times for results. Now, pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – from X-ray images could ease winter pressures on hospitals.

The revolutionary technology developed by researchers at University of the West of Scotland (Scotland, UK) was originally created to quickly detect COVID-19 from X-ray images but has been proven to automatically identify a range of different lung diseases in a matter of minutes, with around 98% accuracy. It is hoped that the technology can be used to help relieve strain on pressured hospital departments through the quick and accurate detection of disease – freeing up radiographers continuously in high demand; reducing waiting times for test results; and creating efficiencies within the testing process.

The state-of-the-art technique utilizes X-ray technology, comparing scans to a database of thousands of images from patients with pneumonia, tuberculosis and COVID. It then uses a process known as deep convolutional neural network – an algorithm typically used to analyze visual imagery – to make a diagnosis. During an extensive testing phase, the technique proved to be 98% accurate. Researchers at UWS are now exploring the suitability of the technology in detecting other diseases using X-ray images, such as cancer.

“There is no doubt that hospital departments across the globe are under pressure and the outbreak of COVID-19 exacerbated this, adding further strain to pressured departments and staff. There is a real need for technology that can help ease some of these pressures and detect a range of different diseases quickly and accurately, helping free up valuable staff time,” said Professor Ramzan, Director of the Affective and Human Computing for SMART Environments Research Centre at UWS, who led the development of the technology. “X-ray imaging is a relatively cheap and accessible diagnostic tool that already assists in the diagnosis of various conditions, including pneumonia, tuberculosis and COVID-19. Recent advances in AI have made automated diagnosis using chest X-ray scans a very real prospect in medical settings.”

Related Links:
University of the West of Scotland


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.